Catalyst Wire Dossier Catalyst Wire Dossier

CD7-targeted cell therapy

CD7-targeted cell therapy · Hebei Senlang Biotechnology Inc., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD7-targeted cell therapy, covering 2024-06-14 to 2024-06-14. Get the full timeline:

Most recent: Clinical Trial Update: Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia [NA]

See pricing